China News Service, Guangzhou, June 20 (Reporter Wang Jian) The opening ceremony of the Guangzhou Biomedical Leading Enterprise Cultivation Project (hereinafter referred to as the "Cultivation Project 'Yuanzhi Class'") was held in Guangzhou on the 19th.
The cultivation project aims to build a linkage mechanism of "politics, academia, research, medicine, production and finance", build a cultivation platform for outstanding biopharmaceutical enterprises, provide policy guidance, technological empowerment, financial services, and industrial linkages, and help Guangzhou biopharmaceutical industry grow. Quality development.
"The biopharmaceutical industry is a strategic industry of technological innovation." Wang Guilin, vice chairman of the Guangzhou Municipal Political Consultative Conference and director of the Science and Technology Bureau, gave the first class to the students of the first phase of the "Yuanzhi Class" of the cultivation project.
He pointed out that Guangzhou is striving to plan a new situation for technological innovation and development, and will gather national strategic scientific and technological forces, focus on jointly building an international technological innovation center in the Guangdong-Hong Kong-Macao Greater Bay Area, and accelerate the construction of a strong city in technological innovation.
Wang Guilin said that at present, Guangzhou has condensed and formed a whole-chain innovation and development path of "scientific discovery, technological invention, industrial development, talent support, and ecological optimization", forming a scientific and technological innovation system with Guangzhou characteristics.
According to reports, as one of the three emerging pillar industries, Guangzhou's biopharmaceutical industry has initially formed the advantages of large-scale and clustered development. In recent years, it has maintained an average annual growth rate of about 10%, and the number of biopharmaceutical enterprises ranks third in the country. It is expected that by 2023, the city's biomedicine and high-end medical device industry scale will strive to exceed 600 billion yuan.
Li Shanmin, vice president of Sun Yat-sen University, said that the cultivation project is of great significance for enterprises to understand innovation policies, enhance innovation awareness, link innovation resources, and develop in the direction of specialization, innovation and standardization. The school will bring Guangzhou's biomedical industry to a higher level. Provide assistance.
Nie Linkun, Secretary of the Party Committee and Chairman of Guangzhou Financial Holding Group, said that the group will play its core functions of industry orientation, scientific research incubation services, application and transformation of achievements, and empowerment of science and technology finance, and make every effort to contribute to the economic and social development of Guangzhou and leading enterprises to become bigger and stronger. Provide various financial and industrial services.
The reporter learned that the first cultivation project brought together 50 high-quality biomedical enterprises in Guangzhou, including 10 listed companies with a total market value of more than 230 billion yuan.
The trainee companies cover the upper, middle and lower reaches of the industrial chain such as biomedicine, inspection and diagnosis, and medical services, as well as investment and professional service institutions focusing on biomedicine, big health track, and will jointly explore new industries, new formats and new models of biomedical economy.
It is reported that the event is supported by Guangzhou Science and Technology Bureau, and is jointly organized by Sun Yat-sen University, Guangzhou Bioengineering Center under Guangzhou Financial Holdings, Guangzhou Science and Technology Finance Group, Guangzhou Bio-Industry Alliance, Ping An Bank Guangzhou Branch, "China Family Doctor" magazine and other units. .
(Finish)